These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21109491)

  • 1. Oesophagogastric junction adenocarcinoma: which therapeutic approach?
    Mariette C; Piessen G; Briez N; Gronnier C; Triboulet JP
    Lancet Oncol; 2011 Mar; 12(3):296-305. PubMed ID: 21109491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of the gastroesophageal junction: combined modality therapy.
    Ilson DH
    Surg Oncol Clin N Am; 2006 Oct; 15(4):803-24. PubMed ID: 17030275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment approaches to esophagogastric junction tumors.
    Kurokawa Y; Sasako M; Doki Y
    Dig Surg; 2013; 30(2):169-73. PubMed ID: 23867594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of postoperative chemoradiotherapy in the therapeutic management of adenocarcinomas of the stomach and oesogastric junction].
    Ben Salah H; Bahri M; Dhouib F; Daoud J
    Cancer Radiother; 2016 Dec; 20(8):830-832. PubMed ID: 27793531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent trends and predictors of multimodality treatment for oesophageal, oesophagogastric junction, and gastric cancer: A Dutch cohort-study.
    Trip AK; Stiekema J; Visser O; Dikken JL; Cats A; Boot H; van Sandick JW; Jansen EP; Verheij M
    Acta Oncol; 2015 Nov; 54(10):1754-62. PubMed ID: 25797568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of the esophago-gastric junction adenocarcinoma].
    Bîrlă R; Losif C; Gîndea C; Hoară P; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(2):143-53. PubMed ID: 18457092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the pathologist in the processing of adenocarcinoma of the stomach, oesophagogastric junction and lower third of the oesophagus].
    Svrcek M; Fléjou JF
    Ann Pathol; 2011 Dec; 31(6):419-26. PubMed ID: 22172114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic classification of adenocarcinoma of the esophagogastric junction.
    Baldus SE
    Recent Results Cancer Res; 2010; 182():29-38. PubMed ID: 20676869
    [No Abstract]   [Full Text] [Related]  

  • 12. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction.
    Pedrazzani C; de Manzoni G; Marrelli D; Roviello F
    J Clin Oncol; 2007 Mar; 25(7):907-8; author reply 908-9. PubMed ID: 17327616
    [No Abstract]   [Full Text] [Related]  

  • 13. [Multimodality therapy for adenocarcinoma of the esophagogastric junction].
    He J; Huang JF
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Sep; 15(9):877-80. PubMed ID: 22990915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the esophagogastric junction: competition between Barrett and gastric cancer.
    Siewert JR; Feith M
    J Am Coll Surg; 2007 Oct; 205(4 Suppl):S49-53. PubMed ID: 17916519
    [No Abstract]   [Full Text] [Related]  

  • 16. [Understanding and controversy of the gastroesophageal junction adenocarcinoma].
    Zhang XH; Wang QZ
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):947-9. PubMed ID: 19174001
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surgical treatment of carcinomas of the oesophagogastric junction - results achieved in multicentre studies].
    Steinert R; Gastinger I; Ridwelski K; Ptok H; Wolff S; Meyer F; Otto R; Lippert H
    Zentralbl Chir; 2013 Aug; 138(4):403-9. PubMed ID: 23950077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
    Bystricky B; Okines AF; Cunningham D
    Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction.
    Lagarde SM; ten Kate FJ; Reitsma JB; Busch OR; van Lanschot JJ
    J Clin Oncol; 2006 Sep; 24(26):4347-55. PubMed ID: 16963732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (Neo)-adjuvant chemo(-radio) therapy for adenocarcinomas of the gastroesophageal junction and the stomach in the West.
    Wilke H; Lordick F; Meyer HJ; Stahl M
    Dig Surg; 2013; 30(2):112-8. PubMed ID: 23867587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.